Clinical Trial Update: Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia [Phase 4]

View source ↗

Summary

This is a Phase 4 trial evaluating ceftriaxone dosage for non-critical community-acquired pneumonia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Community Acquired Pneumonia (CAP) | Phase 4 | Status: NOT_YET_RECRUITING